About Us
Altems Advisory is a academic spin-off that was born from the experience of the Alta Scuola di Economia e Management dei Sistemi Sanitari – ALTEMS of the Università Cattolica del Sacro Cuore – UCSC, active in Rome since 2009
Mission
Propose sustainable and valuable innovations to health systems in response to growing demand from the life science sector
Vision
Use the best scientific evidence to target innovations that can prolong and improve people’s lives and support decisions from an allocative efficiency perspective considering economic and social aspects
Vision
Use the best scientific evidence to target innovations that can prolong and improve people’s lives and support decisions from an allocative efficiency perspective considering economic and social aspects
Investing in people’s health generates benefits for people’s future, making active employment policies more effective, helping to ensure adequate livelihoods, contributing to growth, creating an opportunity to generate investment through improved health
Dario Sacchini
CEO & Partner
He is Associate Professor of Bioethics at the Department of Healthcare Surveillance and Bioethics of Università Cattolica del Sacro Cuore (UCSC). He teaches Bioethics at UCSC “A. Gemelli” School of Medicine (Rome) and at UCSC School of Economics (Rome). His main research fields/expertise in Bioethics are: Ethical domain in Health Technology Assessment (HTA); Ethics Committees; Clinical Ethics. He is member of the following bodies: Board of Directors of Italian Society of HTA (SIHTA); HTA International (HTAi) and past-cochair of HTAi Interest Group on Ethics; Board of the European Association of Centers of Medical Ethics (EACME); Pontifical Academy for Life. Particularly in HTA Ethical domain, he collaborates/collaborated within the following EU Research Projects: European Network for HTA (EUnetHTA) (2006-2021); Integrated health technology assessment for evaluating complex technologies (INTEGRATE-HTA) (2013-15); Values in doing assessments of healthcare technologies (VALIDATE) (2018-2021); Intelligent digital tools for screening of brain connectivity and dementia risk estimation in people affected by mild cognitive impairment (AI-MIND) (2021-25); Novel health care strategies for melanoma in children, adolescents and young adults” (MELCAYA) (2023-26); The first European Digital Health Technology Assessment framework co-created by all stakeholders along the value chain (EDiHTA) (2024-27). He has contributed to the introduction of the HTA Ethical domain in Italy, collaborating within several national HTA processes joined with UCSC Altems Advisory; UCSC VIHTALI; National Institute of Health (ISS); AgeNAS. He contributed to the implementation of the Ethical domain in HTA function at the Fondazione Policlinico Universitario “A. Gemelli” IRCCS since 2008. He is author/coauthor of more than 300 international/national publications.
Michele Basile
Partner & Co-Founder
He is a health economist whose scientific activities focused on the fields of Pharmacoeconomics, decision-making models, Health Technology Assessment (HTA), patient involvement and patient advocacy. His background includes a Master’s Degree in Health Economics achieved at the Università Cattolica del Sacro Cuore and a Master’s Degree in Science in Health Economics achieved at the University of York. He collaborated with the Health Department of the Ospedale Pediatrico Bambino Gesù and Università Cattolica del Sacro Cuore. He is a external consultant of the Department of Epidemiology of Regione Lazio and has been a member of the National Table of the Ministry of Health on Pharmacy Services as an expert. He has been consultant of VIHTALI Srl. Is a member of the scientific secretariat of the Health Policy Forum of SIHTA. He has been didactic coordinator of the Master “Management of biomedical and biotechnological companies” of ALTEMS, Università Cattolica. He has been involved in EU research project: Munros, SPRINT-T, IMPACT HTA, AI-Mind, PROPHET. He has published in journals specialized in Health Economics and clinical journals.
Dario Sacchini
CEO & Partner
He is Associate Professor of Bioethics at the Department of Healthcare Surveillance and Bioethics of Università Cattolica del Sacro Cuore (UCSC). He teaches Bioethics at UCSC “A. Gemelli” School of Medicine (Rome) and at UCSC School of Economics (Rome). His main research fields/expertise in Bioethics are: Ethical domain in Health Technology Assessment (HTA); Ethics Committees; Clinical Ethics. He is member of the following bodies: Board of Directors of Italian Society of HTA (SIHTA); HTA International (HTAi) and past-cochair of HTAi Interest Group on Ethics; Board of the European Association of Centers of Medical Ethics (EACME); Pontifical Academy for Life. Particularly in HTA Ethical domain, he collaborates/collaborated within the following EU Research Projects: European Network for HTA (EUnetHTA) (2006-2021); Integrated health technology assessment for evaluating complex technologies (INTEGRATE-HTA) (2013-15); Values in doing assessments of healthcare technologies (VALIDATE) (2018-2021); Intelligent digital tools for screening of brain connectivity and dementia risk estimation in people affected by mild cognitive impairment (AI-MIND) (2021-25); Novel health care strategies for melanoma in children, adolescents and young adults” (MELCAYA) (2023-26); The first European Digital Health Technology Assessment framework co-created by all stakeholders along the value chain (EDiHTA) (2024-27). He has contributed to the introduction of the HTA Ethical domain in Italy, collaborating within several national HTA processes joined with UCSC Altems Advisory; UCSC VIHTALI; National Institute of Health (ISS); AgeNAS. He contributed to the implementation of the Ethical domain in HTA function at the Fondazione Policlinico Universitario “A. Gemelli” IRCCS since 2008. He is author/coauthor of more than 300 international/national publications
Michele Basile
Partner & Co-Founder
He is a health economist whose scientific activities focused on the fields of Pharmacoeconomics, decision-making models, Health Technology Assessment (HTA), patient involvement and patient advocacy. His background includes a Master’s Degree in Health Economics achieved at the Università Cattolica del Sacro Cuore and a Master’s Degree in Science in Health Economics achieved at the University of York. He collaborated with the Health Department of the Ospedale Pediatrico Bambino Gesù and Università Cattolica del Sacro Cuore. He is a external consultant of the Department of Epidemiology of Regione Lazio and has been a member of the National Table of the Ministry of Health on Pharmacy Services as an expert. He has been consultant of VIHTALI Srl. Is a member of the scientific secretariat of the Health Policy Forum of SIHTA. He has been didactic coordinator of the Master “Management of biomedical and biotechnological companies” of ALTEMS, Università Cattolica. He has been involved in EU research project: Munros, SPRINT-T, IMPACT HTA, AI-Mind, PROPHET. He has published in journals specialized in Health Economics and clinical journals.
Eugenio Di Brino
Partner & Co-Founder
He is a health economist whose scientific activities focused on the fields of Pharmacoeconomics, decision-making models, Health Technology Assessment (HTA), patient involvement and patient advocacy. His background includes a Master of Science in HTA at ALTEMS (Università Cattolica del Sacro Cuore) and a elective course in healt economics modelling at the University of York. He collaborated with the Health Department of the Ospedale Pediatrico Bambino Gesù and Università Cattolica del Sacro Cuore. He has been a member of the National Table of the Ministry of Health on Pharmacy Services as an expert and research assistant at the The National Center for HTA of the Italian National Institute of Health. He has been consultant of VIHTALI Srl and CERISMAS. He is Project Coordinator of Patient Advocacy Lab (PAL) of ALTEMS. Is a member of the scientific secretariat of the Health Policy Forum of SIHTA and he is a member of the scientific technical committee of SIHTA. He is didactic coordinator of the Master “Patient Avocacy Management and International Patient Advocacy Management” of ALTEMS, Università Cattolica. He has been involved in EU research project: Munros, SPRINT-T, IMPACT HTA, PROPHET, UNCAN. He has published in journals specialized in Health Economics and clinical journals.
Filippo Rumi
Partner & Co-Founder
He is a health economist whose scientific activities focused on the fields of Pharmacoeconomics, decision-making models, Health Technology Assessment (HTA), patient involvement and patient advocacy. His background includes a Master’s Degree in Health Economics achieved at the Università Cattolica del Sacro Cuore and a Master’s Degree in Science in Health Economics achieved at the University of York. He collaborated with the World Organization of Healthcare (WHO) in Geneva and Università Cattolica del Sacro Cuore. He has been a member of the National Table of the Ministry of Health on Pharmacy Services as an expert. He has been consultant of VIHTALI Srl. He is a member of the scientific of the Health Policy Forum of SIHTA and a member of the HTA Laboratory of SIFO.
He is lecturer of Pharmacoeconomics in the Farmacy Degree Course at Università Cattolica. He has been involved in EU research project: Munros, SPRINT-T, IMPACT HTA, PROPHET. He has published in journals specialized in Health Economics and clinical journals.
Eugenio Di Brino
Partner & Co-Founder
He is a health economist whose scientific activities focused on the fields of Pharmacoeconomics, decision-making models, Health Technology Assessment (HTA), patient involvement and patient advocacy. His background includes a Master of Science in HTA at ALTEMS (Università Cattolica del Sacro Cuore) and a elective course in healt economics modelling at the University of York. He collaborated with the Health Department of the Ospedale Pediatrico Bambino Gesù and Università Cattolica del Sacro Cuore. He has been a member of the National Table of the Ministry of Health on Pharmacy Services as an expert and research assistant at the The National Center for HTA of the Italian National Institute of Health. He has been consultant of VIHTALI Srl and CERISMAS. He is Project Coordinator of Patient Advocacy Lab (PAL) of ALTEMS. Is a member of the scientific secretariat of the Health Policy Forum of SIHTA and he is a member of the scientific technical committee of SIHTA. He is didactic coordinator of the Master “Patient Avocacy Management and International Patient Advocacy Management” of ALTEMS, Università Cattolica. He has been involved in EU research project: Munros, SPRINT-T, IMPACT HTA, PROPHET, UNCAN. He has published in journals specialized in Health Economics and clinical journals.
Filippo Rumi
Partner & Co-Founder
He is a health economist whose scientific activities focused on the fields of Pharmacoeconomics, decision-making models, Health Technology Assessment (HTA), patient involvement and patient advocacy. His background includes a Master’s Degree in Health Economics achieved at the Università Cattolica del Sacro Cuore and a Master’s Degree in Science in Health Economics achieved at the University of York. He collaborated with the World Organization of Healthcare (WHO) in Geneva and Università Cattolica del Sacro Cuore. He has been a member of the National Table of the Ministry of Health on Pharmacy Services as an expert. He has been consultant of VIHTALI Srl. He is a member of the scientific of the Health Policy Forum of SIHTA and a member of the HTA Laboratory of SIFO.
He is lecturer of Pharmacoeconomics in the Farmacy Degree Course at Università Cattolica. He has been involved in EU research project: Munros, SPRINT-T, IMPACT HTA, PROPHET. He has published in journals specialized in Health Economics and clinical journals.